1. Executive Summary
1.1. Global Actinic Keratosis Treatment Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Actinic Keratosis Treatment Market Outlook, 2018 - 2031
3.1. Global Actinic Keratosis Treatment Market Outlook, by Treatment Type, Value (US$ Mn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Topical Treatment
3.1.1.1.1. 5-fluorouracil Cream
3.1.1.1.2. Diclofenac Ge
3.1.1.1.3. Imiquimod Cream
3.1.1.1.4. Ingenol Mebutate Gel
3.1.1.2. Procedural Modality
3.1.1.2.1. Chemical Peels
3.1.1.2.2. Cryotherapy
3.1.1.3. Photodynamic Therapy
3.1.1.4. Others
3.2. Global Actinic Keratosis Treatment Market Outlook, by Disease Type, Value (US$ Mn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Clinical AK
3.2.1.2. Subclinical AK
3.3. Global Actinic Keratosis Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Private Dermatology Clinic
3.3.1.3. Laser Therapy Centers
3.3.1.4. Cancer Treatment Centers
3.3.1.5. Spas and Rejuvenation Centers
3.3.1.6. Homecare
3.4. Global Actinic Keratosis Treatment Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Actinic Keratosis Treatment Market Outlook, 2018 - 2031
4.1. North America Actinic Keratosis Treatment Market Outlook, by Treatment Type, Value (US$ Mn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Topical Treatment
4.1.1.1.1. 5-fluorouracil Cream
4.1.1.1.2. Diclofenac Ge
4.1.1.1.3. Imiquimod Cream
4.1.1.1.4. Ingenol Mebutate Gel
4.1.1.2. Procedural Modality
4.1.1.2.1. Chemical Peels
4.1.1.2.2. Cryotherapy
4.1.1.3. Photodynamic Therapy
4.1.1.4. Others
4.2. North America Actinic Keratosis Treatment Market Outlook, by Disease Type, Value (US$ Mn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Clinical AK
4.2.1.2. Subclinical AK
4.3. North America Actinic Keratosis Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Private Dermatology Clinic
4.3.1.3. Laser Therapy Centers
4.3.1.4. Cancer Treatment Centers
4.3.1.5. Spas and Rejuvenation Centers
4.3.1.6. Homecare
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Actinic Keratosis Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
4.4.1.2. U.S. Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
4.4.1.3. U.S. Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
4.4.1.4. Canada Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
4.4.1.5. Canada Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
4.4.1.6. Canada Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Actinic Keratosis Treatment Market Outlook, 2018 - 2031
5.1. Europe Actinic Keratosis Treatment Market Outlook, by Treatment Type, Value (US$ Mn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Topical Treatment
5.1.1.1.1. 5-fluorouracil Cream
5.1.1.1.2. Diclofenac Ge
5.1.1.1.3. Imiquimod Cream
5.1.1.1.4. Ingenol Mebutate Gel
5.1.1.2. Procedural Modality
5.1.1.2.1. Chemical Peels
5.1.1.2.2. Cryotherapy
5.1.1.3. Photodynamic Therapy
5.1.1.4. Others
5.2. Europe Actinic Keratosis Treatment Market Outlook, by Disease Type, Value (US$ Mn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Clinical AK
5.2.1.2. Subclinical AK
5.3. Europe Actinic Keratosis Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Private Dermatology Clinic
5.3.1.3. Laser Therapy Centers
5.3.1.4. Cancer Treatment Centers
5.3.1.5. Spas and Rejuvenation Centers
5.3.1.6. Homecare
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Actinic Keratosis Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
5.4.1.2. Germany Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
5.4.1.3. Germany Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.4. U.K. Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
5.4.1.5. U.K. Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
5.4.1.6. U.K. Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.7. France Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
5.4.1.8. France Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
5.4.1.9. France Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.10. Italy Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
5.4.1.11. Italy Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
5.4.1.12. Italy Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.13. Turkey Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
5.4.1.14. Turkey Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
5.4.1.15. Turkey Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.16. Russia Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
5.4.1.17. Russia Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
5.4.1.18. Russia Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.19. Rest of Europe Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
5.4.1.20. Rest of Europe Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
5.4.1.21. Rest of Europe Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Actinic Keratosis Treatment Market Outlook, 2018 - 2031
6.1. Asia Pacific Actinic Keratosis Treatment Market Outlook, by Treatment Type, Value (US$ Mn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Topical Treatment
6.1.1.1.1. 5-fluorouracil Cream
6.1.1.1.2. Diclofenac Ge
6.1.1.1.3. Imiquimod Cream
6.1.1.1.4. Ingenol Mebutate Gel
6.1.1.2. Procedural Modality
6.1.1.2.1. Chemical Peels
6.1.1.2.2. Cryotherapy
6.1.1.3. Photodynamic Therapy
6.1.1.4. Others
6.2. Asia Pacific Actinic Keratosis Treatment Market Outlook, by Disease Type, Value (US$ Mn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Clinical AK
6.2.1.2. Subclinical AK
6.3. Asia Pacific Actinic Keratosis Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Private Dermatology Clinic
6.3.1.3. Laser Therapy Centers
6.3.1.4. Cancer Treatment Centers
6.3.1.5. Spas and Rejuvenation Centers
6.3.1.6. Homecare
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Actinic Keratosis Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. China Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
6.4.1.2. China Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
6.4.1.3. China Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.4. Japan Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
6.4.1.5. Japan Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
6.4.1.6. Japan Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.7. South Korea Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
6.4.1.8. South Korea Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
6.4.1.9. South Korea Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.10. India Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
6.4.1.11. India Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
6.4.1.12. India Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.13. Southeast Asia Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
6.4.1.14. Southeast Asia Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
6.4.1.15. Southeast Asia Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.16. Rest of Asia Pacific Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
6.4.1.17. Rest of Asia Pacific Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
6.4.1.18. Rest of Asia Pacific Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Actinic Keratosis Treatment Market Outlook, 2018 - 2031
7.1. Latin America Actinic Keratosis Treatment Market Outlook, by Treatment Type, Value (US$ Mn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Topical Treatment
7.1.1.1.1. 5-fluorouracil Cream
7.1.1.1.2. Diclofenac Ge
7.1.1.1.3. Imiquimod Cream
7.1.1.1.4. Ingenol Mebutate Gel
7.1.1.2. Procedural Modality
7.1.1.2.1. Chemical Peels
7.1.1.2.2. Cryotherapy
7.1.1.3. Photodynamic Therapy
7.1.1.4. Others
7.2. Latin America Actinic Keratosis Treatment Market Outlook, by Disease Type, Value (US$ Mn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Clinical AK
7.2.1.2. Subclinical AK
7.3. Latin America Actinic Keratosis Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Private Dermatology Clinic
7.3.1.3. Laser Therapy Centers
7.3.1.4. Cancer Treatment Centers
7.3.1.5. Spas and Rejuvenation Centers
7.3.1.6. Homecare
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Actinic Keratosis Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
7.4.1.2. Brazil Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
7.4.1.3. Brazil Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
7.4.1.4. Mexico Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
7.4.1.5. Mexico Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
7.4.1.6. Mexico Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
7.4.1.7. Argentina Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
7.4.1.8. Argentina Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
7.4.1.9. Argentina Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
7.4.1.10. Rest of Latin America Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
7.4.1.11. Rest of Latin America Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
7.4.1.12. Rest of Latin America Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Actinic Keratosis Treatment Market Outlook, 2018 - 2031
8.1. Middle East & Africa Actinic Keratosis Treatment Market Outlook, by Treatment Type, Value (US$ Mn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Topical Treatment
8.1.1.1.1. 5-fluorouracil Cream
8.1.1.1.2. Diclofenac Ge
8.1.1.1.3. Imiquimod Cream
8.1.1.1.4. Ingenol Mebutate Gel
8.1.1.2. Procedural Modality
8.1.1.2.1. Chemical Peels
8.1.1.2.2. Cryotherapy
8.1.1.3. Photodynamic Therapy
8.1.1.4. Others
8.2. Middle East & Africa Actinic Keratosis Treatment Market Outlook, by Disease Type, Value (US$ Mn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Clinical AK
8.2.1.2. Subclinical AK
8.3. Middle East & Africa Actinic Keratosis Treatment Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Private Dermatology Clinic
8.3.1.3. Laser Therapy Centers
8.3.1.4. Cancer Treatment Centers
8.3.1.5. Spas and Rejuvenation Centers
8.3.1.6. Homecare
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Actinic Keratosis Treatment Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
8.4.1.2. GCC Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
8.4.1.3. GCC Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.4. South Africa Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
8.4.1.5. South Africa Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
8.4.1.6. South Africa Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.7. Egypt Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
8.4.1.8. Egypt Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
8.4.1.9. Egypt Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.10. Nigeria Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
8.4.1.11. Nigeria Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
8.4.1.12. Nigeria Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.13. Rest of Middle East & Africa Actinic Keratosis Treatment Market by Treatment Type, Value (US$ Mn), 2018 - 2031
8.4.1.14. Rest of Middle East & Africa Actinic Keratosis Treatment Market by Disease Type, Value (US$ Mn), 2018 - 2031
8.4.1.15. Rest of Middle East & Africa Actinic Keratosis Treatment Market by End User, Value (US$ Mn), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By End User vs By Application Heat map
9.2. Manufacturer vs by Disease Type Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Sun Pharmaceutical Industries Ltd
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Biofrontera
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Nestle SA
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Bausch Health Companies Inc.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Novartis AG
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. GlaxoSmithKline plc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Almirall, LLC
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. LEO Pharma Inc.
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Cipher Pharmaceuticals Inc
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Pierre Fabre Pharmaceuticals, Inc.
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations